Showing results (101-110 of 446) with videos related to
Sort By:
Pageof 45
Mutation Research|October 1, 1990
The mutagenic effects of diacridines and diquinolines in microbial systemsL R Ferguson, P M Turner, W A DennyChemico-Biological Interactions|October 1, 1982
DNA binding and growth inhibitory properties of a series of 2,7-di-alkyl-substituted derivatives of proflavineB C Baguley, L R Ferguson, W A DennyEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiaeB C Baguley, P M Turner, L R FergusonAnti-Cancer Drug Design|June 1, 1988
Microbial mutagenicity of chlorambucil, its half-mustard and mitomycin C: a modified screening strategy for genetic toxicology of bis-alkylating anti-tumour drugsL R Ferguson, B D Palmer, W A DennyMutagenesis|July 1, 1987
Anaerobic incubation and mutagenicity of nitracrine analogues in Salmonella typhimuriumL R Ferguson, A M Roberton, P M TurnerEuropean Journal of Cancer & Clinical Oncology|February 1, 1989
Mutagenicity profiles of newer amsacrine analogues with activity against solid tumours: comparison of microbial and mammalian systemsL R Ferguson, P van Zijl, B C BaguleyAnti-Cancer Drug Design|June 11, 1999
Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylationP R Turner, L R Ferguson, W A DennyEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Genetic toxicology of tricyclic carboxamides, a new class of DNA binding antitumour agentL R Ferguson, C M Hill, B C BaguleyMutation Research|October 1, 1993
Induction of mitotic crossing-over by the topoisomerase II poison DACA (N-[2-dimethylamino)ethyl]acridine-4-carboxamide) in Saccharomyces cerevisiaeL R Ferguson, P M Turner, B C BaguleyMutation Research|August 17, 1996
Mutagenic and carcinogenic properties of platinum-based anticancer drugsB J Sanderson, L R Ferguson, W A DennyPageof 45